What happened to GW Pharmaceuticals stock?

What happened to GW Pharmaceuticals stock?

Jazz Pharmaceuticals (NASDAQ:JAZZ) has officially closed its $7.2B acquisition of GW Pharmaceuticals plc (NASDAQ:GWPH). With the acquisition, Jazz gains access to GW’s cannabinoid portfolio, including Epidiolex, which raked in $510.5M in sales in 2020. …

How much is GW Pharmaceuticals?

Key Turning Points

52-Week High 219.57
Last Price 218.96
Fibonacci 61.8% 168.95
Fibonacci 50% 153.32
Fibonacci 38.2% 137.68

How many employees does GW Pharmaceuticals have?

GW Pharmaceuticals

Type Subsidiary
Total assets $939 million (2020)
Total equity $741 million (2020)
Number of employees 1,161 (2020)
Parent Jazz Pharmaceuticals

Who bought GW Pharma?

Jazz Pharmaceuticals
DUBLIN , May 5, 2021 /PRNewswire/ — Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”), a leader in the science, development and commercialization of cannabinoid-based prescription medicines.

Is GWPH a buy or sell?

The VGM Score are a complementary set of indicators to use alongside the Zacks Rank….Momentum Scorecard. More Info.

Zacks Rank Definition Annualized Return
1 Strong Buy 25.25%
2 Buy 18.80%
3 Hold 10.34%
4 Sell 6.03%

Is GWPH stock a buy?

There are currently 8 hold ratings for the stock. The consensus among Wall Street analysts is that investors should “hold” GW Pharmaceuticals stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GWPH, but not buy additional shares or sell existing shares.

Who bought GW Pharmaceuticals?

A big merger at the intersection of the marijuana and pharmaceutical industries is one step closer to completion. On Friday, shareholders of GW Pharmaceuticals (NASDAQ:GWPH) approved its acquisition by a subsidiary of Jazz Pharmaceuticals (NASDAQ:JAZZ), both companies announced in a joint press release.

How do I buy stock in GW Pharmaceuticals?

Valuing GW Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of GW Pharmaceuticals’s overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Should I keep GWPH?

The consensus among Wall Street research analysts is that investors should “hold” GW Pharmaceuticals stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GWPH, but not buy additional shares or sell existing shares.

Did GW Pharmaceuticals stock split?

Under the terms of the deal, Jazz will pay $220 per American depositary share. That’s split in $200 per ADS in cash and $20 in Jazz ordinary shares. The entire deal values GWPH stock at $7.2 billion, or $6.7 billion net of GW Pharma’s cash. Xenon Pharmaceuticals (XENE) popped 5.4% to 17.16.

What will GW Pharmaceuticals’ stock price reach in the next year?

Their forecasts range from $147.00 to $220.00. On average, they anticipate GW Pharmaceuticals’ stock price to reach $201.75 in the next year. This suggests that the stock has a possible downside of 7.9%.

What is gwgw Pharmaceuticals plc’s (gwph) Q3 earnings report?

GW Pharmaceuticals plc (NASDAQ:GWPH) issued its quarterly earnings data on Tuesday, November, 3rd. The biopharmaceutical company reported ($0.36) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.63) by $0.27.

What does gwgw pharmaceuticals do?

GW Pharmaceuticals Ltd is a United Kingdom-based company that operates as a biopharmaceutical company. The Company manufactures pharmaceutical products. The Company specializes in developing, processing, and manufacturing drugs in pharmaceutical preparations for human and veterinary uses. The Company serves customers worldwide.

How often do you update the “gwph” stock projections?

“GWPH” stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about “GWPH” projections. At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like GW Pharmaceuticals (GWPH).

author

Back to Top